Argenx
ARGX
#438
Rank
โ‚น5.479 T
Marketcap
โ‚น87,673
Share price
0.71%
Change (1 day)
86.93%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

EPS for Argenx (ARGX)

EPS in 2026 (TTM): โ‚น1,415

According to Argenx 's latest financial reports the company's current EPS (TTM) is โ‚น1,501. In 2025 the company made an earnings per share (EPS) of โ‚น2,002 an increase over its 2024 EPS that were of โ‚น1,322.

EPS history for Argenx from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)โ‚น1,415-29.31%
2025โ‚น2,00251.44%
2024โ‚น1,322-369.77%
2023-โ‚น489.98-60.46%
2022-โ‚น1,23963.33%
2021-โ‚น758.71-40.37%
2020-โ‚น1,272183.47%
2019-โ‚น448.87123.09%
2018-โ‚น201.2154.93%
2017-โ‚น129.8714.07%
2016-โ‚น113.8513.05%
2015-โ‚น100.70-36.34%
2014-โ‚น158.19209.04%
2013-โ‚น51.19-33.99%
2012-โ‚น77.55185.59%
2011-โ‚น27.15